{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anti-inflammatory", "Antidiabetic", "Antioxidant", "Cardiac disease", "Enicostemma littorale", "Swertiamarin"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27780133", "DateCompleted": {"Year": "2017", "Month": "02", "Day": "13"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "10", "Day": "22"}], "ELocationID": ["10.1016/j.biopha.2016.10.044", "S0753-3322(16)31321-X"], "Language": ["eng"], "Journal": {"ISSN": "1950-6007", "JournalIssue": {"Volume": "84", "PubDate": {"Year": "2016", "Month": "Dec"}}, "Title": "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie", "ISOAbbreviation": "Biomed Pharmacother"}, "ArticleTitle": "A systematic review of the protective role of swertiamarin in cardiac and metabolic diseases.", "Pagination": {"StartPage": "1051", "EndPage": "1060", "MedlinePgn": "1051-1060"}, "Abstract": {"AbstractText": ["Swertiamarin, is a secoiridoid glycoside found in genera of Enicostemma Species (Enicostemma littorale and Enicostemma axillare) belonging to the family of gentianaceae, which has been reported to cure many diseases such as diabetes, hypertension, atherosclerosis, arthritis, malaria and abdominal ulcers. However, to the best of our knowledge, till date systematic studies to understand the molecular basis of cardiac and metabolic disease preventing properties of swertiamarin has not been reported.", "The present review aims to compile an up-to-date information on the progress made in the protective role of swertiamarin in cardiac and metabolic diseases with the objective of providing a guide for future research on this bioactive molecule.", "Information on the swertiamarin was collected from major scientific databases (Pubmed, Springer, google scholar, and Web of Science) for publication between1974-2016. In this review, the protective role of swertiamarin on cardiac and metabolic diseases was discussed.", "Swertiamarin reported to exhibit a wide range of biological activities such as anti-atherosclerotic, antidiabetic, anti-inflammatory and antioxidant effects. These activities were mainly due to its effect on various signaling pathways associated with cardiac remodeling events such as inhibition of NF-kB expression, LDL oxidation, apoptosis, inflammatory and lipid peroxidation markers and stimulation of antioxidant enzymes.", "Sweriamarin exhibit a wide range of biological activities. This review presents evidence supporting the point of view that swertiamarin should be considered a potential therapeutic agent against cardiac and metabolic diseases, giving rise to novel applications in their prevention and treatment."], "CopyrightInformation": "Copyright \u00a9 2016 Elsevier Masson SAS. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, International Medical University, Bukit Jalil- 57000, Malaysia."}], "LastName": "Leong", "ForeName": "Xin Yu", "Initials": "XY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, International Medical University, Bukit Jalil- 57000, Malaysia. Electronic address: punniyakoti@imu.edu.my."}], "LastName": "Thanikachalam", "ForeName": "Punniyakoti Veeraveedu", "Initials": "PV"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, International Medical University, Bukit Jalil- 57000, Malaysia."}], "LastName": "Pandey", "ForeName": "Manisha", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, International Medical University, Bukit Jalil- 57000, Malaysia. Electronic address: srinivasan_ramamurthy@imu.edu.my."}], "LastName": "Ramamurthy", "ForeName": "Srinivasan", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Meta-Analysis", "Review", "Systematic Review"]}, "MedlineJournalInfo": {"Country": "France", "MedlineTA": "Biomed Pharmacother", "NlmUniqueID": "8213295", "ISSNLinking": "0753-3322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Iridoid Glucosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Pyrones"}, {"RegistryNumber": "4038595T7Y", "NameOfSubstance": "swertiamarin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["adverse effects", "pharmacokinetics", "therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["adverse effects", "pharmacokinetics", "therapeutic use"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Cardiovascular Diseases"}, {"QualifierName": [], "DescriptorName": "Gentianaceae"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["adverse effects", "pharmacokinetics", "therapeutic use"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": ["adverse effects", "pharmacokinetics", "therapeutic use"], "DescriptorName": "Iridoid Glucosides"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Metabolic Diseases"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["adverse effects", "pharmacokinetics", "therapeutic use"], "DescriptorName": "Pyrones"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2016", "Month": "8", "Day": "18"}, {"Year": "2016", "Month": "10", "Day": "5"}, {"Year": "2016", "Month": "10", "Day": "17"}, {"Year": "2016", "Month": "11", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "2", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "11", "Day": "7", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27780133", "10.1016/j.biopha.2016.10.044", "S0753-3322(16)31321-X"]}}], "PubmedBookArticle": []}